MLH1 and colorectal neoplasm: In colorectal neoplasms with methylation in the MLH1 promoter, bisulfite sequencing has demonstrated extensive hemi- or biallelic methylation of the BMP3 promoter; in these tissues silenced expression of BMP3 could be reversed by treatment with 5-Aza-dC and TSA [39].